| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |